Laurion Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $5,460 - $7,909	-195 Reduced 0.23%	83,900 $3.4 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $30,607 - $49,904	-1,033 Reduced 1.21%	84,095 $2.78 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $2.37 Million - $4.31 Million	85,128 New	85,128 $3 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $575,638 - $1.77 Million	-27,998 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$28.14 - $73.01 $787,863 - $2.04 Million	27,998 New	27,998 $1.78 Million
Q2 2018 Aug 13, 2018	SELL	$6.37 - $14.02 $638,789 - $1.41 Million	-100,281 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$3.72 - $7.64 $373,045 - $766,146	100,281 New	100,281 $723,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.